Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWolf Minerals Regulatory News (WLFE)

  • There is currently no data for WLFE

Director/PDMR Shareholding

29 Jun 2018 07:58

RNS Number : 0251T
Wolf Minerals Limited
29 June 2018
Β 

29 June 2018

WOLF MINERALS LIMITED

("WLFE" or the "Company")

DIRECTOR SHAREHOLDING

Wolf Minerals Limited (AIM: WLFE), has today issued to a person closely associated with Mr John Hopkins, Non-Executive Director, 204,428 ordinary shares of no par value in the Company ("Ordinary Shares") in lieu of fees at a rate of A$ 0.0587 per Ordinary Share under the Wolf Minerals Limited Directors' Share Plan as approved by shareholders on 28 November 2017.

Β 

Following the above transaction, Mr John Hopkins has an interest in a total of 1,939,778 Ordinary Shares, representing approximately 0.18 per cent of the issued share capital of the Company.

Β 

1

Details Β of Β the Β person Β discharging Β managerial Β responsibilities Β / Β person Β closely associated Reason for the notification

Β 

a)

Name

John Hopkins

Β 

Β 

2

Reason for the notification

Β 

a)

Position/status

Non-Executive Director

Β 

Β 

b)

Initial notification

/Amendment

Initial Notification

Β 

Β 

Β 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Name

Wolf Minerals Limited

Β 

b)

LEI

213800F9EQEDKGDKZM06

Β 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of Β the financial instrument, type of instrument

Β 

Β 

Identification code

Β 

Fully Paid Ordinary Shares of no par value

Β 

Β 

Β 

ISIN Code of Wolf Minerals Limited Ordinary Shares: AU000000WLF3

Β 

Β 

b)

Nature of the transaction

Issue of securities under the Wolf Minerals Limited Directors' Share Plan as approved by shareholders on 28 November 2017.

Β 

Β 

Β 

c)

Price(s) and volume(s)

Β 

Prices

Volumes

A$ 0.0587

(equivalent to ~3.3p)

204,428

Β 

Β 

d)

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

204,428

Β 

AUD $12,000

e)

Date of the transaction

29 June 2018

f)

Place of the transaction

Outside a trading venue

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHSEDSMUFASEIM
Date   Source Headline
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:01 amRNSAppendix 3Y
30th Jun 20177:01 amRNSIssue of Equity and Change of Directors' Interests
29th Jun 20179:15 amRNSReplacement of Grant of ASX Listing Rule Waivers
28th Jun 20173:15 pmRNSASX Listing Waivers for Bridge Facility Increase
28th Jun 20173:15 pmRNSBridge Facility with RCF Increased
16th Jun 20177:00 amRNSIssue of Equity
16th Jun 20177:00 amRNSAppendix 3B
16th May 20177:00 amRNSCancellation of Lapsed Performance Rights
15th May 20179:05 amRNSAppendix 3Z
15th May 20179:05 amRNSResignation of Director
8th May 20177:00 amRNSAppendix 3X
8th May 20177:00 amRNSInterim MD, Richard Lucas, Appointed to Wolf Board
28th Apr 20177:00 amRNSQuarterly Activities Report
28th Apr 20177:00 amRNSAppendix 5B
7th Apr 201710:19 amRNSDirectorate Change
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSCleansing Notice Letter
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSIssue of Equity and Change of Directors' Interests
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3B
16th Mar 20177:02 amRNSInterim Financial Statements
13th Mar 20177:35 amRNSUpdate on Bridge Facility with RCF
20th Feb 20174:41 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
10th Feb 20179:20 amRNSCancellation of Lapsed Performance Rights
6th Feb 20177:00 amRNSRevised Securities Dealing Policy
31st Jan 20177:00 amRNSAppendix 5B
31st Jan 20177:00 amRNSQuarterly Activities Report
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3B
30th Dec 20168:10 amRNSCleansing Notice Letter
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:09 amRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20161:15 pmRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.